Search - tctmd.com

Displaying 321 - 340 of 422

Sort: Relevancy | Date

Presentation TCT 2012

Resistant Hypertension: Prevalence and Global Impact

Presenter: Stefan Bertog

October 24, 2012

Presentation TCT 2012

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

Physiologic Rationale for Interventional Therapies in Hypertension

Presenter: C. Venkata S. Ram

October 24, 2012

Presentation TCT 2012

OneShot (Maya Medical)

Presenter: John Ormiston

October 24, 2012

Presentation TCT 2012

Obstructive Sleep Apnea

Presenter: Adam Witkowski

October 24, 2012

Presentation TCT 2012

Moderate Hypertension and ESRD

Presenter: Markus Schlaich

October 24, 2012

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Lessons Learned Using the Symplicity Catheter 1: Procedural Do's and Don'ts

Presenter: Andreas Baumbach

October 24, 2012

Presentation TCT 2012

Hypertension Therapies: A Word of Caution

Presenter: Peter Fitzgerald

October 24, 2012

Presentation TCT 2012

External Focused Ultrasound (Kona)

Presenter: Todd Brinton

October 24, 2012

Presentation TCT 2012

Diabetes/Metabolic Syndrome

Presenter: Felix Mahfoud

October 24, 2012

Presentation TCT 2012

Catheter-Based Technology Alternatives for Renal Denervation

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Beyond Renal Denervation

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Approach to the Patient with Renal Failure and Multivessel CAD

Presenter: Harry Phillips

October 24, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

Presenter: Giuseppe Sangiorgi

October 23, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Advertisement

Resistant Hypertension: Prevalence and Global Impact

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Physiologic Rationale for Interventional Therapies in Hypertension

OneShot (Maya Medical)

Obstructive Sleep Apnea

Moderate Hypertension and ESRD

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Lessons Learned Using the Symplicity Catheter 1: Procedural Do's and Don'ts

Hypertension Therapies: A Word of Caution

External Focused Ultrasound (Kona)

Diabetes/Metabolic Syndrome

Catheter-Based Technology Alternatives for Renal Denervation

Beyond Renal Denervation

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Approach to the Patient with Renal Failure and Multivessel CAD

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content